Skip to content
10-Q

Quarterly Report

Bio-En Holdings Corp.

0001410578-21-000255

← back to feed
Filed
Nov 15, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Sep 30, 2021 77.35M sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $26.2K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $11.71K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $195
Cash And Equivalents Q3 2021 · Dec 31, 2019 $420
Stockholders Equity Q3 2021 · Sep 30, 2021 −$453.5K
Stockholders Equity Q3 2021 · Dec 31, 2020 −$442.78K
Current Liabilities Q3 2021 · Sep 30, 2021 $479.7K
Current Liabilities Q3 2021 · Dec 31, 2020 $469.49K
Total Liabilities Q3 2021 · Sep 30, 2021 $479.7K
Total Liabilities Q3 2021 · Dec 31, 2020 $469.49K
Current Assets Q3 2021 · Sep 30, 2021 $26.2K
Current Assets Q3 2021 · Dec 31, 2020 $26.71K
Total Assets Q3 2021 · Sep 30, 2021 $26.2K
Total Assets Q3 2021 · Dec 31, 2020 $26.71K
Operating Income Q3 2021 · Sep 30, 2021 $13.71K
Operating Income restated Q3 2021 · Sep 30, 2020 $11.24K
Operating Income restated Q3 2021 · Sep 30, 2020 $46.17K
Revenue Q3 2021 · Sep 30, 2021 $0
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$235.23K
Net Income Q3 2021 · Sep 30, 2020 −$11.24K
Net Income Q3 2021 · Sep 30, 2020 −$281.17K